Sickle cell disease (SCD) is one of the most prevalent and severe monogenetic disorders. Previously, we generated iPS cell lines from SCD patients. Here, we generated iPS cell lines from three age-, ethnicity-and gender-matched healthy individuals as control cell lines. Cell reprogramming was performed using erythroblasts expanded from PBMC by a non-integrative method. SCD-iPSC controls expressed pluripotency markers, presented a normal karyotype, were able to differentiate into the three germ layers in embryoid body spontaneous differentiation and confirmed to be integration-free. The cell lines generated here may be used as matched healthy controls for SCD studies. 
Resource utility
The iPSC lines generated can be used as healthy controls in experiments conducted with the sickle-cell disease iPSC lines previously generated by our group (Martins et al., 2018) . Sickle cell disease (SCD) is a monogenic disease but the mechanisms involved on its phenotypic heterogeneity remains unclear (Driss et al., 2009) . It is considered a major health problem in Brazil, especially in the state of Bahia, where its prevalence is about 6% to 10% among heterozygote individuals (Cançado and Jesus, 2007) , and its incidence is 1:650 in newborns (Brazilian Ministry of Health, 2014) . SCD patient-derived (Martins et al., 2018) and age-and sex-matched control iPS cell lines from different ethnic origins provide useful tools for studies aiming at addressing the influence of genetic diversity in the disease pathogenesis, drug discovery and gene editing. These cell lines may also be used as normal T controls for studies of other hemoglobinopathies and disorders where the age, gender and ethnicity are a match.
Resource details
Peripheral blood mononuclear cells (PBMCs) were collected from healthy donors, according to approved institutional procedures. Healthy donors were screened by hemoglobin electrophoresis, showing normal pattern. The written informed consent was obtained from all individuals. To generate the iPSCs from age and sex-matched control individuals, we delivered episomal expression cassettes of human OCT3/4, SOX2, KLF4, MYCL, LIN28, and shRNA of TP53 (Okita et al., 2011) into PBMC-derived erythroblasts by nucleofection. The clones were picked, expanded and analyzed for confirmation of the pluripotency state. The iPSCs generated grew as round colonies with a typical human embryonic stem cell (hESC)-like morphology (Fig. 1A , scale bar 100 μm). The percentage of TRA-1-60 + cells -a pluripotency marker -was determined by flow cytometry analysis (Fig. 1B) and confirmed by immunostaining for TRA-1-60 and other pluripotency markers -OCT3/4, NANOG and SOX2 (Fig. 1C , scale bar 25 μm). The loss of the episomal vectors used for cell reprogramming was confirmed by PCR for EBNA1 at P20 (Fig. 1D ). Chromosomal stability was confirmed by G-band karyotyping analysis at passage 15 ( Fig. 1E) showing no numerical or structural clonal alterations. The expression of endogenous pluripotency genes was detected by RT-PCR (Fig. 1F) . All of the iPSC lines demonstrated the ability to generate derivatives of the three-germ layers in an embryoid body (EB)-based assay. Generated EBs presented the typical morphology (Fig. 1G , scale bar 100 μm) and were positive for differentiation markers of ectoderm (Nestin), mesoderm (smooth muscle actin, alpha-SMA) and endoderm (alpha fetoprotein, AFP) (Fig. 1H , scale bar 25 μm) while undifferentiated iPSCs were negative for the differentiation markers ( Supplementary Fig. 1 ). Evaluation of gene expression markers of endoderm (AFP), mesoderm (MSX1) and ectoderm (TUBB3) were also detected by RT-PCR (Fig. 1I) . All cell lines were tested for Mycoplasma sp., showing negative results ( Supplementary Fig. 2 ). Finally, genetic fingerprinting was performed by STR analysis, confirming the genetic identity to parental PBMCs (available with the authors) (See Tables 1 and 2 .)
Materials and methods

Reprogramming of erythroblasts expanded from peripheral blood mononuclear cells (PBMC)
Peripheral blood was collected and diluted 1:1 in 0.9% NaCl. PBMCs were isolated by density gradient centrifugation using Ficoll-Paque®-1077 (Sigma-Aldrich). PBMCs were cultured in StemSpan supplemented with Erythroid Expansion Medium (SSEM, Stemcell Technologies), according to the manufacturer's instructions. Erythroblast expansion was confirmed by flow cytometry with anti-CD36 and anti-CD71 antibodies. Cell reprogramming was performed by nucleofection of the expanded erythroblasts with episomal plasmids encoding for OCT4, SOX2, KLF4, MYCL, LIN28, a short hairpin RNA for TP53 (shP53), and EBNA1 (Addgene plasmids #27077, #27078 and #27080, and #41857), using the Nuclelofection kit P3 solution and Nucleofector 4D, program EO-100 (Lonza). The nucleofection was performed using 2 × 10 6 cells and 2 μg of each plasmid. The cells were then plated in SSEM and ReproTeSR (Stem Cell Technologies) at D0. From reprogramming to D15 to D20, small colonies with an ESC-like appearance were observed. Colonies were manually picked based on the morphology and cultured in plates coated with Matrigel hESCqualified matrix (Corning) in mTESR1 medium (Stem Cell Technologies) or Essential 8 (E8, Gibco). All cells were maintained at 37°C in a humidified atmosphere containing 5% CO 2 , with daily media exchanges until 80-90% confluency was achieved. The selected SCDiPSC lines were routinely passaged using 0.5 mM EDTA or 15 mM Sodium citatre/135 mM KCl solution, once a week, with 1:10 split ratio, or twice a week with 1:6 split ratio, being cryopreserved in liquid nitrogen in mTeSR1 containing 10% DMSO. Stem Cell Research 38 (2019) 101454 In vitro differentiation by embryoid body (EB) formation assay SCD-Control-iPS cells cultured in 6 well-plates were harvested using Accutase (Gibco) for 5 min at 37°C. Cells were washed and resuspended in 1 mL of EB medium: DMEM Knockout supplemented with 20% KOSR, 1% Non-Essential Amino Acids, 1× Glutamax, 1% Penicillin/ Streptomycin (all from Thermo Fisher Scientific) and 10 μM Y-27632 (Stemcell Technologies). Next, 150 μL of a 6 × 10 4 cells/mL cell suspension were transferred to each well of a 96 U bottom non-adherent plate (Corning) for EB formation. Half of the media was replaced twice a week, for 2 weeks. Then, EBs were plated in 24 well-plates previously coated with Matrigel (Corning). EBs were cultured with EB medium for one week and then were fixed with PFA 4%, for immunofluorescence analysis, or incubated with Trizol (ThermoFisher Scientific), for RNA extraction and RT-PCR assays.
Immunofluorescence (IF) analysis
SCD-Control-iPS cells grown on cover slips were fixed with 4% paraformaldehyde for 15 min and permeabilized with 0.1% Triton X-100 (Sigma-Aldrich) in PBS for 15 min at RT. Non-specific binding was blocked with Casblock (Thermofisher Scientific) in PBS for 30 min. Primary antibodies for the pluripotency markers Oct-4, Nanog, Sox2, TRA-1-60, diluted in 0.1% BSA in PBS, were added and cells were then incubated overnight at 4°C. On the following day, the cells were incubated with secondary antibodies for 1 h at RT. Nuclei were stained with DAPI (Vector Labs). Staining for three germ layer markers on EB spontaneous differentiation assay was performed as described above, with anti-AFP, anti-SMA, and anti-Nestin antibodies. All dilutions and antibodies manufacturers are described in Table 3 . Slides were observed and images were acquired using a confocal microscope, Nikon A1 (Tokyo, Japan). Paredes, et al. Stem Cell Research 38 (2019) 101454 Flow cytometry SCD-Control-iPSCs were dissociated using TrypLE™ Express (Thermo Fischer Scientific), and incubated with the antibody TRA-1-60-Alexa Fluor 647 or Mouse IgM-Alexa Fluor 647 Isotype Control (BD Biosciences) diluted in PBS for 15 min at RT. The cells were washed and resuspended in PBS 1× + Hoecsht 33342 (2 μg/mL) for live cell data acquisition using a LSR Fortessa SORP flow cytometer (BD Biosciences). Data analysis was performed using FlowJo v.X (Tristar).
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was extracted from samples using TRIZOL (ThermoFisher Scientific) and 1 μg of RNA was used for cDNA synthesis using the VILO™ SuperScript™ kit according to the manufacturer's instructions. The cDNA was treated with DNAse (Ambion) and then used to perform a PCR for LIN28, SOX2, NANOG, OCT3/4, AFP, MSX1, TUBB3 and the housekeeping gene GAPDH, using primers described at Table 3 . PCR assays were performed using Platinum Taq DNA Polymerase (Invitrogen) and PCR Proflex System equipament (Applied Biosystem). Cycle parameters for LIN28: 94°C 2 min, 94°C 30 s, 65°C sec, 72°C 1 min (30×), 72°C 10 min; SOX2: 94°C 2 min, 94°C 30 s, 62°C sec, 72°C 1 min (30×), 72°C 10 min; NANOG: 94°C 2 min, 94°C 30 s, 52°C sec, 72°C 1 min (30×), 72°C 10 min; OCT3/4: 94°C 2 min, 94°C 30 s, 58°C sec, 72°C 1 min (30×), 72°C 10 min. Cycle parameters for AFP, MSX1, TUBB3: 94°C 2 min, 94°C 30 s, 62°C sec, 72°C 1 min (35×), 72°C 10 min. PCR products were confirmed by electrophoresis on agarose gel 2%.
Short tandem repeat (STR) analysis
STR analyses were performed by pairing the parental cell source (PBMCs) of each donor and respective iPSC line. Briefly, genomic DNAs were isolated using Puregene® Core Kit A, amplified by PowerPlex Fusion System (Promega) and then analyzed with ABI3500 (Applied Biosystem) genetic analyzer using the software program GeneMapper v.5.0 (Applied Biosystem).
Karyotype analysis
Chromosomes were prepared at P15 after colcemid (10 μg/ml) overnight at 37°C (5% CO2, 95% rH) were incubated in hypotonic solution (KCl 0.75%, 15 min, 90°C), washed 3 min with acetic acid 5% and fixed with methanol/acetic acid (3:1). G-banded metaphase images were acquired with a 100× objective (Olympus BX61 microscope and ProgRes MFcool camera). Analysis were conducted in 20 metaphases using Lucia Karyo software (Lucia Cytogenetics) with a 400-450 band resolution.
Analysis of plasmid integration
Genomic DNA was isolated from parental PBMCs and CBTCi002-A, CBTCi003-A, CBTCi004-A using Puregene® Core Kit A (Qiagen). PCR was performed using primers specific to EBNA1 (Table 3) . The DNA was separated by 2% agarose gel electrophoresis. The DNA from parental PBMC and mixture of episomal were used as negative and positive controls respectively. GAPDH was used as an endogenous control. PCR assays were performed as described above. PCR conditions: 94°C 2 min, 94°C 30 s, 66°C 30 s, 72°C 1 min (35×), 72°C 10 min.
Mycoplasma testing
Testing for mycoplasma contamination was performed using by MycoAlert detection kit (LONZA) according to the manufacturer's protocol.
Supplementary data to this article can be found online at https:// doi.org/10.1016/j.scr.2019.101454.
